Table 3 The changes of mRS after DFPP treatments within a week for different neuronal surface antibodies
Antibodies | n |
|---|---|
NMDAR | 16 |
Effective | 10 (62.5%) |
No respond | 5 (31.3%) |
Worse | 1 (6.3%) |
GABA-BR | 5 |
Effective | 1(20%) |
No respond | 3 (60%) |
Worse | 1 (20%) |
LGI1 | 3 |
Effective | 2 (66.7%) |
No respond | 1 (33.3%) |
Worse | 0 (0.00%) |
AMPAR | 2 |
Effective | 2 (100%) |